SSRIs for Treatment of Pruritus
Sertraline is the most effective SSRI for treating pruritus, particularly in cholestatic and uremic itch, and should be considered as a third-line treatment option after first-line cholestyramine and second-line rifampicin. 1
Types of Pruritus Responsive to SSRIs
SSRIs work by increasing serotonin concentrations, which can modulate itch perception at both peripheral and central levels. The evidence supports their use in several types of pruritus:
Cholestatic Pruritus
Uremic Pruritus
- Sertraline has demonstrated effectiveness in end-stage renal disease patients 4
- Can significantly reduce the severity of pruritus in hemodialysis patients
Polycythemia Vera-Associated Pruritus
- SSRIs are recommended as a treatment option 1
- Often used when other treatments like aspirin, cytoreductive therapy, or interferon-alpha are ineffective
Treatment Algorithm for Pruritus
First-line treatments:
Second-line treatments:
Third-line treatments:
Dosing and Administration
- Sertraline: Start at 25-50 mg daily and titrate up to 75-100 mg daily as needed and tolerated
- Paroxetine: Typically 20 mg daily
- Fluvoxamine: Start at 50 mg daily, can increase to 100 mg daily
Monitoring and Side Effects
- Monitor for common SSRI side effects: nausea, headache, insomnia, sexual dysfunction
- Rare but important: Some patients may experience paradoxical worsening of pruritus with SSRIs 6
- Elderly patients may be more sensitive to side effects and should start at lower doses
- Drug interactions should be carefully considered, especially with other serotonergic medications
Special Considerations
- Hepatic impairment: Use caution with sertraline in severe liver disease; may need dose reduction
- Renal impairment: Generally safe but monitor closely
- Pregnancy: Risk-benefit assessment needed; generally category C
- Pediatric use: Sertraline has been used successfully in children with cholestatic pruritus at 1-4 mg/kg/day 3
Treatment Duration
- Initial trial of 4-8 weeks to assess efficacy
- If effective, treatment may be continued long-term as needed
- Periodic attempts at dose reduction or discontinuation may be reasonable in patients with sustained improvement
Limitations and Caveats
- Evidence for SSRI use in pruritus is primarily from small studies and case reports
- Individual response may vary significantly
- May take 2-4 weeks to see maximum benefit due to SSRI mechanism of action
- Not FDA-approved specifically for pruritus treatment
SSRIs represent an important option in the treatment algorithm for pruritus, particularly for patients who have failed first- and second-line therapies. Sertraline has the strongest evidence base among the SSRIs for this indication.